Hepatitis A is a temporary liver infection caused by the hepatitis A virus. Symptoms include diarrhea, dark urine, fatigue, fever, nausea, vomiting, pain, and jaundice, yellowing of the eyes and skin.

GSK's experimental drug to treat chronic hepatitis B infection met the main goal in two closely watched studies, the ...

GSK will be filing for approval of bepirovirsen in hepatitis B to global regulatory authorities based on the Phase III data.

Researchers suggest adding a new drug boceprevir to a two-drug treatment can enhance outcomes for hepatitis C patients, according to a USA Today news report. The drugs currently used to treat ...

According to the Centers for Disease Control and Prevention, more than 2 million people in the U.S. are infected with hepatitis C. The bloodborne illness attacks the liver and can lead to cancer or ...

Hepatitis B viral load is the amount of hepatitis B virus (HBV) found in a person’s bloodstream. Hepatitis B is a viral infection that can pass from person to person through bodily fluids. It ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. LEWISTON — Looking back, Rosie Boyce does not recall experiencing many ...

The CHB therapeutics market offers growth opportunities via emerging functional cures like bepirovirsen and selgantolimod, amidst challenges from patent expiries and generic erosion. Strategic R&D, ...

Gilead Sciences moved one step closer to an all-oral cure for hepatitis C on Monday when the company submitted its application to the Food and Drug Administration to market sofosbuvir for the viral ...